BRK-B vs JHI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
JHI presents a classic value trap profile, characterized by a stable Piotroski F-Score of 5/9 and significant undervaluation relative to its Graham Number ($19.68) and Intrinsic Value ($34.22). While the company boasts impressive operating margins and a low P/E ratio compared to the sector, these strengths are offset by critical liquidity concerns and an unsustainable dividend policy. The current price of $13.30 is well below fair value estimates, but the technical trend is bearish and the payout ratio exceeds 100%. Consequently, the stock is a high-yield play with significant fundamental risks regarding solvency and dividend maintenance.
Compare Another Pair
Related Comparisons
BRK-B vs JHI: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and John Hancock Investors Trust (JHI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.